Navigation Links
Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix™ Biliary Stents
Date:10/21/2010

while navigating tight strictures in the bile ducts, facilitating stent placement and removal.  The thin wall and increased inner diameter of the stent may provide extended patency of the duct, which could improve treatment outcomes."

"Boston Scientific remains committed to delivering innovation and leadership in endoscopic stent technology," said Michael Phalen, Senior Vice President, and President of Boston Scientific's Endoscopy Division.  "The Advanix Biliary Stent System represents the latest advances in plastic stent design, enabling physicians to more efficiently and effectively treat blockages in the bile duct.  In addition, it strengthens our broad stent portfolio and provides another solution for the ERCP suite."

Benign strictures in the bile duct are typically caused by prior surgical procedures, biliary stones or chronic pancreatitis, a disease in which digestive enzymes begin to break down and attack the pancreas.  Chronic pancreatitis is extremely painful and in severe cases, can lead to infection, shock and respiratory failure.  The most common cause of malignant biliary obstruction is pancreatic cancer, which is rarely diagnosed in the early stages, and is the second most common cause of death among gastrointestinal cancers.  Other causes of malignant biliary obstructions include bile duct, liver and gallbladder cancer.  

The Advanix Biliary Stent and NaviFlex RX Delivery System are available in a variety of sizes and shapes to accommodate both malignant and benign biliary strictures, distinct patient anatomies and physician preferences.  

About Boston ScientificBoston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.  For more information, please visit: www.bostonscientific.com.  

About Boston Scienti
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Announces Results for Third Quarter Ended September 30, 2010
2. Boston Scientific Announces Global Launch of Journey™ Guidewire
3. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
4. Boston Scientific Welcomes Publication of Analysis Demonstrating Long-Term Survival Benefit for ICD Therapy
5. Boston Scientifics TAXUS® Element™ Stent Demonstrates Strong Outcomes in Diabetic Patients
6. Boston Scientific Announces Clinical Data Supporting Safety and Efficacy of Platinum Chromium PROMUS Element™ Stent
7. Boston Scientific to Acquire Asthmatx
8. Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds
9. Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
10. Boston Millennia Partners Portfolio Company CardioMEMS Signs Equity Investment and Exclusive Option to be Acquired for an Additional $375,000,000
11. Childrens Hospital Boston and Particle Sciences Cooperate on Translational Medicine Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces that a ... catalogue: Global Orthopedic Soft Tissue Repair ... About Orthopedic Soft Tissue ... of cells that connect, support, or surround bones. ... such as tendons, ligaments, cartilage, fascia, and other ...
(Date:8/27/2014)...  Decision Resources Group finds that physicians surveyed ... gastroenterology, endocrinology and nephrology) expect the robustness and ... been assessed in to be the strongest influencers ... Other key findings from the ... of Biosimilars Across Physician Specialties : ...
(Date:8/27/2014)... Mass. , Aug. 27, 2014 Decision ... that characterized the Memphis health ... way to clinical integration, with rivals Methodist Le Bonheur ... respective physician groups to coordinate patient care. In addition, ... which has the most health plan enrollment in the ...
Breaking Medicine Technology:Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 5Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2Memphis-area Health Systems Turn Attention to Clinical Integration 2
... 2011 Centre Partners Management LLC ("Centre Partners"), a leading ... and Los Angeles, today announced the completion of the sale ... Troy Limited (Nasdaq: HELE). Kaz is an international leader in ... valued at $260 million subject to certain closing working capital ...
... The MED Group, a Managed Health Care Associates, Inc. ...  The website was created to help answer questions for ... about competitive bidding and how patients can receive their ... Centers for Medicare and Medicaid Services (CMS) will be ...
Cached Medicine Technology:Centre Partners Announces Successful Realization of Investment in Kaz, Inc. 2Centre Partners Announces Successful Realization of Investment in Kaz, Inc. 3New Program for Medicare Beneficiaries Will Mean Major Changes Effective January 1, 2011 - Florida 2New Program for Medicare Beneficiaries Will Mean Major Changes Effective January 1, 2011 - Florida 3
(Date:8/27/2014)... of hormone therapy has spawned a prevalent but preventable ... hot flashes, according to a study by a Yale ... the study published in the Aug. 27 online issue ... that moderate to severe hot flashes also called ... women. Women with VMS experience more than feeling hot; ...
(Date:8/27/2014)... (PDT, which uses topical agents and light to kill ... common skin lesion caused by sun damage) at three ... to freeze lesions). , Author: Gayatri Patel, ... Center, in Sacramento, and colleagues. , Background: ... found on individuals with fair complexions who have had ...
(Date:8/27/2014)... Michigan Head & Neck Institute is hosting a school ... school by ensuring they have everything they need for a ... Michigan Head & Neck Institute wants to ensure the children ... "There are a lot of military families in the area, ... back to our community," said Lauren Taylor, Marketing Coordinator at ...
(Date:8/27/2014)... Dr. Stewart Shofner and Dr. Kevin ... suffering from impaired vision. Some of the most common ... . Recently, Dr. Shofner has noticed a significant increase ... and also online. To help patients understand the facts, ... , 1)    Myth: People with perfect vision won’t develop glaucoma. ...
(Date:8/27/2014)... Washington, New York (PRWEB) August 27, 2014 ... dedicated to protecting the rights of victims injured by ... new rules in place for discovery procedures, specifically Collection ... brought over C.R. Bard’s transvaginal mesh devices. (MDL No. ... Products Liability Litigation, the United States District Court, Southern ...
Breaking Medicine News(10 mins):Health News:The high cost of hot flashes: Millions in lost wages preventable 2Health News:Photodynamic therapy vs. cryotherapy for actinic keratoses 2Health News:Michigan Head & Neck Institute is Conducting Their 2nd Annual School Supplies Drive at Their Facility to Benefit Local Year-Round Elementary School Students 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 4Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 2Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 4
... Catalyst,Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) today ... Third Quarter 2007 Results For the quarter ... of $734,347 or $0.06 loss per basic and diluted ... loss per basic and diluted share for the,same period ...
... Nov. 14 (HealthDay News) -- A protein that may have ... be a biomarker that indicates severe asthma. And it may ... to new research. , Reporting in the Nov. 15 issue ... University researchers said that people with severe asthma were more ...
... aim . . . , As the ... a high performance bullet based on technology developed at ... precision and superior terminal ballistics and is lead-free and ... Wakeman, Ohio, the technology is first being made available ...
... Reason for their added survival remains unclear, scientists say ... Hispanics appear to live longer following an Alzheimer,s diagnosis ... men and women of Asian and American Indian descent ... expectancies equivalent to that of white Alzheimer,s patients, ...
... December 31, RICHARDSON, Texas, Nov. 14 Blue ... will offer three Medicare Part D,prescription drug plans with ... Medicare beneficiaries in Texas can sign up,for or switch ... open enrollment period, which begins November 15 and continues ...
... Inc. announced today that CC Detect(SM), the ... now available from Panacea,Laboratories. CC Detect(SM) is ... identification of individuals with cancer of the ... standard screening methods. Panacea Laboratories,a division of ...
Cached Medicine News:Health News:Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results 2Health News:Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results 3Health News:Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results 4Health News:Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results 5Health News:Defensive Protein Linked to Asthma 2Health News:Defensive Protein Linked to Asthma 3Health News:Story tips from the Department of Energy's Oak Ridge National Laboratory, Nov. 2007 2Health News:Blacks, Hispanics Live Longer With Alzheimer's 2Health News:Blacks, Hispanics Live Longer With Alzheimer's 3Health News:Blacks, Hispanics Live Longer With Alzheimer's 4Health News:Blue Cross and Blue Shield of Texas Announces Flexible, Affordable Blue MedicareRx(SM) Medicare Prescription Drug Plans 2Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 2Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 3Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 4Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 5
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: